ANTI-CD123 CHIMERIC ANTIGEN RECEPTOR REDIRECTED T CELLS FOR RELAPSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

被引：0
|
作者：
Ruella, M. [1 ]
Shestova, O. [1 ]
Kenderian, S. [1 ]
Barrett, D. [2 ]
Grupp, S. [2 ]
Scholler, J. [1 ]
Lacey, S. [1 ]
Kalos, M. [1 ]
June, C. H. [1 ]
Gill, S. [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
来源：
CYTOTHERAPY | 2014年 / 16卷 / 04期
关键词：
D O I：
10.1016/j.jcyt.2014.01.017
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
5
引用
下载
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [31] Advances in the development of chimeric antigen receptor-T-cell therapy in B-cell acute lymphoblastic leukemia
    Zhang Xian
    Li Jing-Jing
    Lu Pei-Hua
    中华医学杂志(英文版), 2020, 133 (04) : 474 - 482
  • [32] Influence of patient characteristics on chimeric antigen receptor T cell therapy in B-cell acute lymphoblastic leukemia
    Furun An
    Huiping Wang
    Zhenyun Liu
    Fan Wu
    Jiakui Zhang
    Qianshan Tao
    Yingwei Li
    Yuanyuan Shen
    Yanjie Ruan
    Qing Zhang
    Ying Pan
    Weiwei Zhu
    Hui Qin
    Yansheng Wang
    Yongling Fu
    Zhenqing Feng
    Zhimin Zhai
    Nature Communications, 11
  • [33] Anti-CD19 chimeric antigen receptor T-cell therapy for B-cell acute lymphoid leukemia
    Rapoport, Aaron P.
    HAEMATOLOGICA, 2024, 109 (04) : 1019 - 1020
  • [34] Anti-CD19 chimeric antigen receptor T-cell therapy for B-cell acute lymphoid leukemia
    Rapoport, Aaron P.
    REVISTA CHILENA DE LITERATURA, 2024, (109): : 1019 - 1020
  • [35] Sustained Therapeutic Efficacy of Humanized Anti-CD19 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Acute Lymphoblastic Leukemia
    Heng, Gang
    Jia, Jiankun
    Li, Shiqi
    Fu, Gang
    Wang, Meiling
    Qin, Dabing
    Li, Yunyan
    Pei, Li
    Tian, Xiaobo
    Zhang, Jiasi
    Wu, Yi
    Xiang, Shali
    Wan, Jia
    Zhu, Wei
    Zhang, Pei
    Zhang, Qianzhen
    Peng, Xi
    Wang, Linling
    Wang, Ping
    Wei, Zhihao
    Zhang, Yingzi
    Wang, Guiqin
    Chen, Xue
    Zhang, Chengcheng
    Sun, Yanni
    Zhao, Wenxu
    Fan, Yahan
    Yang, Zhi
    Chen, Jieping
    Qian, Cheng
    CLINICAL CANCER RESEARCH, 2020, 26 (07) : 1606 - 1615
  • [36] Efficacy of CD19-targeted chimeric antigen receptor T cells in the treatment of relapsed extramedullary B-cell acute lymphoblastic leukemia (B-ALL) and diffuse large B-cell lymphoma (DLBCL).
    Hu, Yongxian
    Wu, Zhao
    Yu, Jian
    Wang, Jiasheng
    Wei, Guoqing
    Wu, Wenjun
    Luo, Yi
    Shi, Jimin
    Xiao, Lei
    Huang, He
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [37] Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia
    Haso, Waleed
    Lee, Daniel W.
    Shah, Nirali N.
    Stetler-Stevenson, Maryalice
    Yuan, Constance M.
    Pastan, Ira H.
    Dimitrov, Dimiter S.
    Morgan, Richard A.
    FitzGerald, David J.
    Barrett, David M.
    Wayne, Alan S.
    Mackall, Crystal L.
    Orentas, Rimas J.
    BLOOD, 2013, 121 (07) : 1165 - 1174
  • [38] BALANCE OF ANTI-CD123 CHIMERIC ANTIGEN RECEPTOR (CAR) BINDING AFFINITY AND DENSITY IN AN IN VITRO MODEL OF ACUTE MYELOID LEUKEMIA
    Arcangeli, S.
    Bardelli, M.
    Rotiroti, M. C.
    Simonelli, L.
    Magnani, C. F.
    Biondi, A.
    Biagi, E.
    Tettamanti, S.
    Varani, L.
    HAEMATOLOGICA, 2016, 101 : 124 - 124
  • [39] Chimeric antigen receptor therapy for T-cell acute lymphoblastic leukemia: finally catching up with B-cell leukemia?
    Beyar-Katz, Ofrat
    Rowe, Jacob M.
    HAEMATOLOGICA, 2024, 109 (06) : 1631 - 1633
  • [40] BALANCE OF ANTI-CD123 CHIMERIC ANTIGEN RECEPTOR (CAR) BINDING AFFINITY AND DENSITY IN AN in vitro MODEL OF ACUTE MYELOID LEUKEMIA
    Arcangeli, S.
    Bardelli, M.
    Rotiroti, M. C.
    Simonelli, L.
    Magnani, C. F.
    Biondi, A.
    Biagi, E.
    Tettamanti, S.
    Varani, L.
    HAEMATOLOGICA, 2016, 101 : S41 - S41
12345